Compare CGEM & UPWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CGEM | UPWK |
|---|---|---|
| Founded | 2016 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | 2020 | 2018 |
| Metric | CGEM | UPWK |
|---|---|---|
| Price | $20.04 | $8.47 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 11 |
| Target Price | ★ $30.13 | $22.73 |
| AVG Volume (30 Days) | 589.4K | ★ 4.2M |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.44 |
| Revenue | N/A | ★ $787,784,000.00 |
| Revenue This Year | N/A | $9.06 |
| Revenue Next Year | $5.20 | $13.57 |
| P/E Ratio | ★ N/A | $19.66 |
| Revenue Growth | N/A | ★ 2.40 |
| 52 Week Low | $5.68 | $7.44 |
| 52 Week High | $21.00 | $22.84 |
| Indicator | CGEM | UPWK |
|---|---|---|
| Relative Strength Index (RSI) | 69.02 | 41.43 |
| Support Level | $11.87 | $7.61 |
| Resistance Level | N/A | $9.53 |
| Average True Range (ATR) | 1.17 | 0.43 |
| MACD | 0.26 | -0.14 |
| Stochastic Oscillator | 83.33 | 25.62 |
Cullinan Therapeutics Inc is a clinical-stage biopharmaceutical company developing therapies for autoimmune diseases and cancer. Its development pipeline comprises the following drug candidates: CLN-978, a CD19xCD3 bispecific T cell engager that is being developed for autoimmune diseases; CLN-049, a FLT3xCD3 bispecific T cell engager being evaluated in an ongoing clinical trial in patients with relapsed/refractory acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS); Velinotamig, a BCMAxCD3 bispecific T cell engager being developed to counter autoimmune diseases; and Zipalertinib, being developed as a treatment for non-small cell lung cancer. Additionally, the company is developing several preclinical programs in autoimmune diseases and oncology.
Upwork Inc is a United States-based company that operates an online marketplace that enables businesses to find and work with skilled independent professionals. The company develops platform for hiring and freelancing purposes and connects businesses with AI-enabled talent across every on-demand work type, including freelance, agency, fractional, and payrolled. The business generates revenue from Talent and Clients across the USA, India, Pakistan, the Philippines and the rest of the world. Maximum revenue of the company is derived from Talent segment.